DECIBEL THERAPEUTICS
Decibel Therapeutics is a developer of hearing disorder therapeutics intended to protect, repair and restore hearing. The company's therapeutics have provided insights into the link between hearing dysfunction and inner ear pathology and it has capabilities to encompass animal models, drug delivery to the inner ear, imaging, inner ear PK/PD modeling and measurement, bioinformatics, genetics and target identification, enabling patients to experience hearing loss therapies with different forms of hearing disorders for their recovery.
DECIBEL THERAPEUTICS
Industry:
Biotechnology Medical Device Therapeutics
Founded:
2015-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.decibeltx.com
Total Employee:
51+
Status:
Active
Contact:
(617) 370-8701
Total Funding:
189.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Global Site Tag
Similar Organizations
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Goldfinch Biopharma
Goldfinch is a clinical-stage biotech company focused on discovering and developing precision therapies for patients with kidney disease.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Advisors List
Board_member
Board_member
Board_member
2019-01-01
Current Employees Featured
Erik Larsen Senior Director, Product and Market Strategy @ Decibel Therapeutics
Senior Director, Product and Market Strategy
2016-03-07
Gabriel Corfas Founder @ Decibel Therapeutics
Founder
2015-10-01
M. Charles Liberman Founder @ Decibel Therapeutics
Founder
Ronald Vigliotta VICE PRESIDENT, FINANCE @ Decibel Therapeutics
VICE PRESIDENT, FINANCE
John J. Keilty Chief Data Sciences Officer @ Decibel Therapeutics
Chief Data Sciences Officer
2017-01-01
Anna Trask EVP and CHIEF PEOPLE, COMMUNITY and CULTURE OFFICER @ Decibel Therapeutics
EVP and CHIEF PEOPLE, COMMUNITY and CULTURE OFFICER
2018-01-01
Heather Wolff VICE PRESIDENT, CLINICAL DEVELOPMENT OPERATIONS @ Decibel Therapeutics
VICE PRESIDENT, CLINICAL DEVELOPMENT OPERATIONS
Elisabeth Leiderman CFO @ Decibel Therapeutics
CFO
2020-01-01
Laurence Reid Chief Executive Officer @ Decibel Therapeutics
Chief Executive Officer
2020-11-01
John J. Lee Chief Development Officer @ Decibel Therapeutics
Chief Development Officer
2021-02-01
Founder
Stock Details
Investors List
Janus Henderson Investors
Janus Henderson Investors investment in Series D - Decibel Therapeutics
BlackRock
BlackRock investment in Series D - Decibel Therapeutics
SR One
SR One investment in Series D - Decibel Therapeutics
S-Cubed Capital
S-Cubed Capital investment in Series D - Decibel Therapeutics
Casdin Capital
Casdin Capital investment in Series D - Decibel Therapeutics
GV
GV investment in Series D - Decibel Therapeutics
Foresite Capital
Foresite Capital investment in Series D - Decibel Therapeutics
Sobrato Capital
Sobrato Capital investment in Series D - Decibel Therapeutics
Third Rock Ventures
Third Rock Ventures investment in Series D - Decibel Therapeutics
Surveyor Capital
Surveyor Capital investment in Series D - Decibel Therapeutics
Official Site Inspections
http://www.decibeltx.com Semrush global rank: 2.55 M Semrush visits lastest month: 6.9 K
- Host name: ec2-52-1-152-253.compute-1.amazonaws.com
- IP address: 52.1.152.253
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Decibel Therapeutics"
Decibel Therapeutics - Crunchbase Company Profile & Funding
Decibel Therapeutics is a developer of hearing disorder therapeutics intended to protect, repair and restore hearing. The company's therapeutics have provided insights into the link between …See details»
Working At Decibel Therapeutics: Company Overview and Culture
Mar 14, 2024 www.decibeltx.com. Organization Type. Public. CEO. Laurence E. Reid. Social Media. Decibel Therapeutics is a developer of hearing disorder therapeutics intended to …See details»
Decibel Therapeutics Company Overview, Contact Details
Nov 9, 2020 Decibel Therapeutics. Biotechnology Research Massachusetts, United States 51-200 Employees. Decibel Therapeutics is a clinical-stage biotechnology company dedicated to …See details»
Decibel Therapeutics Information - RocketReach
Decibel Therapeutics is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, one of the …See details»
Decibel Therapeutics Overview | SignalHire Company Profile
Decibel Therapeutics is a public company that has been in the industry for 9 years. The company currently specializes in the Biotechnology, Pharmaceuticals areas. The position of the …See details»
Decibel Therapeutics - Overview, News & Similar companies
Jun 2, 2023 Decibel Therapeutics contact info: Phone number: (617) 370-8701 Website: www.decibeltx.com What does Decibel Therapeutics do? Founded in 2013 and headquartered …See details»
Decibel Therapeutics - businessabc
Sep 27, 2024 Decibel Therapeutics was founded in 2017 by three scientists at Harvard Medical School and Massachusetts Institute of Technology. Since then, the company has grown to a …See details»
Decibel’s Competitors, Revenue, Number of Employees, Funding
Decibel’s Profile, Revenue and Employees. Decibel Therapeutics is a Massachusetts-based biotechnology company that researches and develops drugs for the treatment of ear, nose, …See details»
Decibel Therapeutics CEO and Key Executive Team | Craft.co
Decibel Therapeutics's Vice President, New Product Planning is Bridget Cleff. Other executives include Elaine Cope, Vice President, Operations; Elaine Kernbauer, Vice President, …See details»
Regeneron to Acquire Decibel Therapeutics, Strengthening Gene …
Aug 9, 2023 Proposed acquisition builds on existing collaboration between Decibel and Regeneron, will accelerate and further resource key gene therapy programs for hearing loss …See details»
Decibel Therapeutics (USA) Funding: $189.2M
Nov 7, 2024 Decibel Therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair and restore...See details»
Decibel Therapeutics: Employee Directory | ZoomInfo.com
Decibel Therapeutics Contact Info: Website: www.decibeltx.com What does Decibel Therapeutics do? Founded in 2013 and headquartered in Boston, Massachusetts, Decibel Therapeutics, …See details»
AS397744 Decibel Therapeutics, Inc. details - IPinfo.io
Decibeltx.com: Hosted domains: 0 Number of IPv4: 256 Number of IPv6: ... but for smaller organizations it may be that organization's parent, or their ISP. Find out more about AS397744 …See details»
Decibel Therapeutics - VentureRadar
Open PageRank: 2,182,459 | decibeltx.com. VentureRadar Popularity. High. VentureRadar Popularity: High. The popularity score combines profile views, clicks and the number of times …See details»
Decibel Therapeutics Inc - WhaleWisdom.com
Decibel Therapeutics, Inc. engages in discovering and developing transformative treatments for hearing and balance disorders. The company's lead gene therapy product candidate is DB …See details»
Decibel Therapeutics | Tinnitus Talk Support Forum
Jan 9, 2019 Central to the mission of the organization is facilitating and supporting biomedical research which will lead to novel, effective therapies for the treatment of hyperacusis. The …See details»
Decibel Therapeutics to Present at the Association for Research in ...
Boston, Mass. – February 6, 2019 – Decibel Therapeutics will showcase capabilities across its inner ear-focused drug discovery and development platform at the 42 nd annual mid-winter …See details»
Decibel & Catalent partner for Hearing Loss Gene Therapy
Feb 4, 2021 Decibel’s pipeline, including its lead gene therapy program, DB-OTO, to treat congenital, monogenic hearing loss, is designed to deliver on our vision of a world in which the …See details»
Decibel Therapeutics to Present at the 43rd Annual Association for ...
Boston, Mass. — January 24, 2020 — Decibel Therapeutics, a development-stage biotechnology company creating novel therapeutics for hearing loss and balance disorders, will present new …See details»
Developing transformative treatments for hearing and balance
Email:licensing@decibeltx.com CONTACT. Title: 00136905-1.pdf Created Date: 8/26/2021 7:08:14 PM ...See details»